What the latest on mRNA vaccines means for cancer
Reported byNPR Health ↗·Sourced by Goodlede
A 72-year-old woman became the world's first recipient of an mRNA vaccine designed to treat pancreatic cancer seven years ago and now shows zero evidence of the disease that was expected to be fatal. In a 16-patient trial, the vaccine worked on eight patients, seven of whom remain alive. Merck and Moderna also released results showing mRNA vaccines reduced recurrence and death rates in skin cancer trials.
This is an early-stage trial; longer-term outcomes and broader safety/efficacy data across larger populations are still being gathered. mRNA vaccines for cancer are not yet in routine clinical use.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at NPR Health
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Human Feats
Karl Bushby completes 28-year, 31,000-mile walk around the world and returns to his mother's house
Associated Press · Verified
Environment
Electric trucks hit 50% of China's heavy truck sales, diesel demand falls
Electrek · Verified
David vs Goliath
TD tried to make grieving mom pay $38K in student debt after daughter died of cancer
CBC Canada · Verified